Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes.Cancer Nanotechnologyaims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of resea...
develop within the area in the next few years. With this in mind,Cancer Nanotechnologyaims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology....
Cancer Nanotechnology《癌症纳米技术》 国际标准刊号:ISSN 1868-6958;EISSN 1868-6966 核心类别:SCIE(2022版), 目次收录(超星), 目次收录(知网),外文期刊, 投稿网址:submission.nature.com/n 期刊网址:cancer-nano.biomedcentral.com 所属分区:3区 是否TOP:非TOP期刊 是否综述:非综述期刊 是否OA:OA期刊 期刊简介...
Molecular Cancer invites submissions to this article collection. This Collection aims to explore innovative research and breakthrough developments in the application of nanotechnology for cancer diagnosis, treatment, and management. The collection is open to submissions till 31 March 2025.Special...
The addition of the cyclin dependent kinase inhibitor (CDKi) dinaciclib to Poly-(ADP-ribose) polymerase inhibitor (PARPi) therapy is a strategy to overcome resistance to PARPi in tumors that exhibit homologous recombination (HR) deficiencies as well as to expand PARPi therapy to tumors that do...
C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 66, 2–25 (2014). Article CAS PubMed Google Scholar Maeda, H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as ...
Saritha GNG, Anju T, Kumar A. Nanotechnology: big impact: how nanotechnology is changing the future of agriculture? J Agric Food Res. 2022;10: 100457. CASGoogle Scholar Hu Q, Fang Z, Ge J, Li H. Nanotechnology for cardiovascular diseases. Innovation. 2022;3(2): 100214. ...
C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 66, 2–25 (2014). Article CAS Google Scholar Venditto, V. J. & Szoka, F. C. Jr. Cancer nanomedicines: so many papers and so few drugs! Adv. Drug ...
This nanometer-scale bending allows them to be in the category of nanotechnology even though its whole size is in the micrometer-scale and can be used as a component of biosensors. Microcantilevers have been applied to pH detection [110,111], protein detection [112-117], DNA/RNA-DNA/RNA ...
Journal Impact Factor: 4.5 5-year Journal Impact Factor: 5.1 Source Normalized Impact per Paper (SNIP): 0.723 SCImago Journal Rank (SJR): 0.671 Speed 2024 Submission to first editorial decision (median days): 9 Submission to acceptance (median days): 107 ...